Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rajib Shome, Ph.D.

Concepts (56)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Rajib Shome's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Rajib Shome has written about over time.
Cell Survival, 3 publications between 2019 and 2021, average publication date August 2020. Cell Line, Tumor, 5 publications between 2017 and 2024, average publication date September 2020. Drug Resistance, Multiple, 2 publications between 2021 and 2021, average publication date March 2021. Reactive Oxygen Species, 2 publications between 2021 and 2021, average publication date March 2021. Cell Hypoxia, 1 publications between 2021 and 2021, average publication date May 2021. Gold, 1 publications between 2021 and 2021, average publication date May 2021. Nanostructures, 1 publications between 2021 and 2021, average publication date May 2021. Penicillamine, 1 publications between 2021 and 2021, average publication date May 2021. Transferrin, 1 publications between 2021 and 2021, average publication date May 2021. Copper, 2 publications between 2021 and 2021, average publication date August 2021. Epithelial-Mesenchymal Transition, 3 publications between 2021 and 2024, average publication date March 2022. beta Catenin, 2 publications between 2021 and 2024, average publication date October 2022. Neoplastic Stem Cells, 1 publications between 2024 and 2024, average publication date April 2024. Single-Cell Analysis, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Shome's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.